Keeping up with international frontier and promoting research and development of pharmacoeconomics in China  

作　　者：Shanlian Hu Shanshi Yang Wei Cai 

机构地区：[1]School of Public Health,Fudan University,Shanghai,200032,China [2]Shanghai Health Development Research Center,Shanghai,200032,China

出　　处：《Pharmacoeconomics and Policy》2025年第1期2-4,共3页药物经济与政策(英文)

摘　　要：Since the Second Asia-Pacific Health Economics and Outcomes Research Conference was first held in Shanghai in 2006,pharmacoeconomics has developed rapidly in China over the past two decades.^(1-3 )Currently,there are nine Pharmacoeconomics Committees and International Society for Pharmacoeconomics and Outcomes Research(ISPOR)regional Chapters throughout in China,including Hong Kong Chapter,Shanghai Chapter,Beijing Chapter,Northeast China Chapter,South China Chapter,Southwest China Chapter,Northwest China Chapter,Chinese Medical Doctor Association Chapter,and Taiwan Chapter.Similar parties include the Health Technology and Economic Evaluation Professional Committee of the China Health Economics Association,etc.They are all professional research teams with more than 1000 members engaged in health technology assessment and pharmacoeconomics research,aiming to enhance research capabilities.Related national and regional workshops and seminars are held annually,and there are various training courses conducting before the conferences.

关 键 词：annually FRONTIER NORTHWEST 

分 类 号：F42[经济管理—产业经济]